These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 31400712

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
    Testa U, Lo-Coco F.
    Ann Hematol; 2016 Apr; 95(5):673-80. PubMed ID: 26920716
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [All-trans retinoic acid/arsenic trioxide combination therapy for a patient with acute promyelocytic leukemia on dialysis].
    Nagao R, Hosoba R, Yahagi Y, Gunji T, Uryu H, Hattori D, Momoki M, Yamazaki H.
    Rinsho Ketsueki; 2019 Apr; 60(10):1431-1435. PubMed ID: 31695003
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial.
    Zhang L, Zou Y, Chen Y, Guo Y, Yang W, Chen X, Wang S, Liu X, Ruan M, Zhang J, Liu T, Liu F, Qi B, An W, Ren Y, Chang L, Zhu X.
    BMC Cancer; 2018 Apr 03; 18(1):374. PubMed ID: 29615003
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Tissue factor-bearing microparticles are a link between acute promyelocytic leukemia cells and coagulation activation: a human subject study.
    Zhao H, Sun J, Yan L, Jin B, Hou W, Cao F, Li H, Zhou J, Zhang Y.
    Ann Hematol; 2021 Jun 03; 100(6):1473-1483. PubMed ID: 33893844
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study.
    Baysal M, Gürsoy V, Hunutlu FC, Erkan B, Demirci U, Bas V, Gulsaran SK, Pinar IE, Ersal T, Kirkizlar TA, Atli EI, Kirkizlar HO, Ümit EG, Gürkan H, Ozkocaman V, Ozkalemkas F, Demir AM, Ali R.
    Ann Hematol; 2022 May 03; 101(5):1049-1057. PubMed ID: 35190843
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Characteristics and prognosis analysis of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide as the front-line therapy.
    Lou Y, Suo S, Tong H, Ye X, Wang Y, Chen Z, Qian W, Meng H, Mai W, Huang J, Tong Y, Jin J.
    Leuk Res; 2013 Nov 03; 37(11):1451-6. PubMed ID: 23958062
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia.
    Tallman MS, Abutalib SA, Altman JK.
    Semin Thromb Hemost; 2007 Jun 03; 33(4):330-8. PubMed ID: 17525890
    [Abstract] [Full Text] [Related]

  • 39. Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia.
    Zhao S, Ge Y, Li Z, Yang T.
    Front Immunol; 2023 Jun 03; 14():1100151. PubMed ID: 37063881
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.